Acinetobacter baumannii, a hospital-acquired pathogen
A. baumannii is a Gram-negative, opportunistic pathogen commonly found in soil, water, hospital sinks, bed sheets of patients, health care settings, human body skin, and hospital settings [1]. This organism is often associated with nosocomial infections with high mortality and morbidity rates in intensive care units (ICUs) responsible for approximately 2%–10% of all Gram-negative hospital-acquired infections worldwide [1, 2]. The isolates are often collected from the sputum, central nervous system, burn and wound, blood, and urine of patients with prolonged ICU stays [3, 4]. Interestingly, A. baumannii exhibits high resilience to tough environmental conditions and survives on medical devices for extended periods [5]. This durability is attributed to its ability to form biofilm and secrete toxic compounds that can lead to the death of adjacent cells by direct contact [6, 7]. A. baumannii also exhibits high genomic plasticity, adapting to various environmental conditions such as the presence of antibiotics, heavy metal ions, disinfectants, and elevated temperatures [8, 9]. As part of the ESKAPE organisms, A. baumannii poses a global threat to human health and presents a therapeutic challenge due to the emerging, increasing, and spread of antibiotic-resistance genes in Multidrug-resistant A. baumannii (MDR) strains which have been reported worldwide, leading to the high mortality rate in critically ill patients in ICUs [10]. In addition, the emergence and prevalence of carbapenem-resistant (CRAB) MDRAB strains attributed to a significant increase in mortality rates compared to non-CARB-resistant strains in the ICU [11,12]. This organism causes several hospital infections such as ventilator-associated pneumonia (VAP), bloodstream infections (BSI), wound and skin infections, soft tissue, and urinary tract infections in patients with immunocompromised systems or those with underlying conditions [13-15]. Besides, CRAB isolates have been designated as the top priority pathogen requiring urgent management for treatment by the World Health Organization (WHO) [16]. It is now upgraded to a number 1 public health threat by the CDC in the USA (https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf). However, CARB isolates are now problematic across Asia and the Americas, except in Japan and Canada. Moreover, Oceania, Western Europe, the Nordic region, and part of central Europe have the lowest rate (<10%), however, in areas surrounding the Mediterranean, including southern Europe, the Middle East, the Indian subcontinent, and North Africa, A. baumannii clinical isolates that are resistant to carbapenems raised to 90% [17, 18]. Factors contributing to the spread of CARB isolates indicate poor antimicrobial stewardship programs and high administration in management of hospital hygiene and load of antibiotics in hospital settings [19]. Furthermore, the emergence and spread of extensive drug-resistant (XDR) and pan-drug-resistant (PDR) strains of A. baumannii in ICUs worldwide, poses a significant threat as many isolates do not respond to any antibiotic treatment [20]. In light of these challenges, which require a detailed understanding of this organism’s pathobiology, comprehensive strategies for antibiotic administration must be developed to reduce the propensity of infection by MDR strains of this microorganism.
Type VI Secretion System in A. baumannii
Many Gram-negative bacteria can thrive in competitive polymicrobial communities when faced with extreme environmental conditions in the soil, aquatic environments, and healthcare settings [21]. They implement this by injecting toxic effector molecules into neighboring cells, leading to cell death. This behavior is especially prominent among soil microbiota, which compete for vital micronutrients, cationic ions, and growth factors essential for survival in nutritionally deprived ecosystems. As a result, the bacteria have developed various secretory mechanisms to overcome such difficult conditions. One key mechanism is the type VI secretion system (T6SS), first identified in soil-resident bacteria [22]. The T6SS is crucial for the survival of bacterial host cells in unfavorable conditions, allowing them to eliminate adjacent cells through direct contact [23]. This macromolecular nanomachine acts as a syringe and needle to inject toxic effector proteins into neighboring prokaryotic and eukaryotic cells while protecting itself and sister cells with complex cognate immunity genes, typically located upstream or downstream of the corresponding T6SS effector [24]. Four different subtypes of T6SSs have been described in the literature (T6SSi-iv), with variations in the number of conserved components, and low homology among subtypes proteins [25]. It is estimated that 60% of proteobacteria acquired this system by horizontal gene transfer through mobile genetic elements. On the other hand, T6SS structural clusters are present in over 25 % of Gram-negative bacteria, varying in number from one to six different genetic clusters per organism [26]. Many pathogens use the T6SS to escape immune cells, eliminate commensal bacteria, and facilitate infection [27]. T6SS cluster plasticity suggests evolutionarily divergent systems were acquired horizontally by genetic elements like plasmids, transposons, and integrons [28]. Five distinct phylogenetic groups containing T6SS genes have evolved. Despite this, the main component of the T6SS system, particularly the core genes that encode T6SS structural components, remains highly conserved across various bacterial species, indicating a fundamental role in their functionality [29]. Additionally, the system confers advantages for invading eukaryotic cells and functions as a virulence factor, since certain toxic effectors can kill eukaryotic cells by inducing either apoptosis or necrosis, in both cases targeting cells releases cytokines like TNF-α, interleukins, and interferon-ɣ all which cause inflammatory response [30]. For instance, Vibrio cholerae V5 delivers a toxic effector that interferes with the host cytoskeleton of intestinal cells, similarly, Folkesson et al., [31] reported that in the case of Salmonella enterica, a genomic island [Salmonella centrisome island (SCI)] related to the IcmF gene cluster is associated with eukaryotic cell invasion of the epithelial cells and cause death. The T6SS machinery can transport effector proteins in two ways to targeted cells, i) either by fusion with structural components or ii) by non-covalent interaction with one of the core T6SS protein components in both cases, the effector's molecule is associated with the Hcp/VgrG/PAAR structure complex essential for the activity of T6SS (injectosome) [32]. A. baumannii can acquire antibiotic-resistant genes, secretion systems, and various enzymes, including phospholipases, DNase, and peptidoglycan-hydrolyzing amidase genes from other pathogenic bacteria through gene transfer phenomenon [33]. Analysis of the architecture and building block of the T6SS in this bacterium revealed that the core components comprise 13 essential genes that are clustered together occupying about 25% of its total genomic content [34]. Some of the T6SS baseplate components have also been identified as structural homologues of T4 bacteriophage proteins. The similarities between the Hcp, VgrG, and TssE proteins and three subunits associated with the bacteriophage tails (bacteriophage T4 gp19, gp27–gp5, and gp25, respectively) indicate an evolutionary transfer gene of this component to bacteria [35]. Subsequent, evaluation of function using in silico study and Cryo-electron microscopy tomography method indicates that assembly of the T6SS baseplate follows a pathway similar to that of the T4 phage, in contrast, the membrane proteins originate from the bacterium itself [36, 37]. For example, protein-protein interaction studies and protease susceptibility assays indicated that TssM undergoes an ATP binding-induced conformational change and that subsequent ATP hydrolysis is crucial for recruiting Hcp to interact with the periplasmic domain of the TssM-interacting protein TssL (an IcmH/DotU family protein) into a ternary complex and mediating Hcp1 secretion [38]. Normally, the inner Hcp tube assembles onto the base of VgrG and extends into the cytoplasm. A few extended Hcps might carry diverse toxins in their C-termini to serve as T6SS effectors [39]. Furthermore, T6SS-active clinical strains were found to survive better in the presence of human serum and were more frequently detected in patients with catheter-related bloodstream infection, hematopoietic stem cell transplantation, and immunosuppressive agent therapy [33]. Higher hcp expression was found to increase the invasiveness of A. baumannii under respiratory infection and could be triggered by the acid environment [33]. In Acinetobacter baylyi, this structure has a syringe-like shape and is often used by bacteria to deliver toxic substances into the other cells. The effectors may constitute extensions of any of the secreted components Hcp, VgrG, or PAAR, or bind non-covalently to these in terms of cargo’ effectors [40]. The process is a one-step mechanism where bacterial cytoplasmic substrates are conveyed directly into a target cell or to the extracellular space. The operational mechanism of the T6SS macromolecule is divided into three stages: 1) assembly of components to form the active T6SS complex (syringe and needle structure), 2) delivery phase, where the effector molecule triggers the contraction of Hcp1 with the help of VgrG1(gp27) contractile sheath and TssB/C, resulting in the propelling of the effector molecule through the Hcp1 nanotube towards the targeted cell, (the energy for this function obtains from hydrolysis of ATP molecule by ClpV-ATPase cleavage, and 3) disassembly phase, during which the toxin effector is released into target cell led to cell death through various mechanisms [41]. The sequence analysis of the VgrG, Hcp, and PAAR proteins by Boyer et al., [42] confirmed that some C-terminal regions possess domains for binding effector molecules showing similarities with adhesins or proteins with enzymatic functions. In A. baumannii, the T6SS system is negatively regulated by the acquisition and loss of plasmid DNA containing the regulatory genes characterized by three conserved regions: a locus encoding the type IV secretion system (T4SS) conjugative machinery; a region encoding two TetR transcriptional regulators for example, conjugative plasmid pAB3 produce proteins within the H-NS family control the expression of Hcp1 nanotube [43].
Rotameric shift and conformational change in protein structure
A critical aspect of forecasting protein structure and its interactions with various compounds, including toxic agents or peptide ligands, is the evaluation of side chain flexibility [44]. A rotameric shift is characterized by a shift in the dihedral angles (ϕ, ψ) of an amino acid's side chain, either clockwise or counterclockwise, leading to a conformational change in that amino acid configuration. Each amino acid possesses a unique set of rotamers, and a comprehensive collection of these rotamers for all amino acids can be organized into libraries [45]. The rotamericity of an amino acid is fundamentally influenced by the diverse environments encountered in actual protein structures. The elements such as the torsional angles of the backbone residue and the protein's secondary structure play a role in altering the dihedral angles of the amino acid side chain [46]. It has been proposed that torsional angles can either directly influence the dihedral rotation of the backbone (φ between Cα and N, ψ between Cα and Cω, and between C and N) or indirectly impact the side chains of amino acids (χ1 between Cα and Cβ, χ2 between Cβ and Cγ) [47]. Rotamers can be classified as backbone-independent, secondary-structure-dependent, or backbone-dependent, with distinctions made based on dihedral angles and conformations. Backbone-dependent predictions result in rotameric shifts in both the backbone (χ1/χ2, and Cγ) and the dihedral angles (ϕ, ψ) of amino acids, whereas, backbone-independent rotamer libraries reflect the frequencies and average dihedral angles for all side chains in proteins, irrespective of each residues conformation [48]. Research indicates that backbone-dependent rotamer libraries offer considerable advantages over their backbone-independent counterparts, particularly when utilized as an energy term, as they enhance the efficiency of side-chain packing algorithms employed in protein structure prediction [49]. Moreover, the condition for matching side chain conformations must be the same as that used for the evaluation next to the last rotamer library where a correct position must lie within 40° in each χ dihedral [50]. Usually, a rotational angle is in the apo form or Holo form (bound state). The rotamer frequencies are primarily due to steric repulsions between backbone atoms Cγ whose position depends on φ and ψ side chain heavy atoms. Moreover, the φ and ψ angles of amino acids can be determined by the Ramachandran plot [50].
The purpose of this study is to exploit the mechanism of contraction of the Hcp1 tail/tube complexes upon binding to a specific toxic effector molecule in the A. baumannii by employing machine learning techniques such as AI and Deep learning systems along with bioinformatics databases. The study also aims to analyze the structures, functions, and domain analysis attributes of A. baumannii T6SS, as well as to examine the phylogenetic tree relationships, and to classify Hcp and VrgG1 of T6SS components.